| Home | E-Submission | Sitemap | Editorial Office |  
top_img
       
ORIGINAL ARTICLE 2025 August 27
Systemic immune-inflammation index prior to postoperative radiotherapy as a tool for outcome prediction in thymic epithelial tumors
Purpose: The systemic immune-inflammation index (SII) is a prognostic biomarker in various solid tumors. However, the prognostic role of SII in thymic epithelial tumors (TETs) receiving adjuvant radiotherapy (RT) has not yet been explored. This study aims to assess the prognosti...
ORIGINAL ARTICLE 2025 December 8
Postmastectomy radiation therapy for patients with pT1-2N1 breast cancer over 2 decades in Korea: Korean Radiation Oncology Group 14-21
Purpose: This study investigates patterns of postmastectomy radiation therapy (PMRT) use in patients with pT1–2N1 breast cancer treated with mastectomy in Korea over 2 decades. Materials and Methods: Data from 700 patients treated at 16 institutions across three decades (1990,...
ORIGINAL ARTICLE 2025 December 8
Can lymphocytic toxicity be induced by radiation dose to the bowel bag in whole pelvic radiotherapy?
Purpose: Lymphocytopenia is a known side effect of radiation exposure to the bone marrow. However, the hematological impact of irradiating the bowel bag—a highly vascularized region containing numerous mesenteric lymph nodes—remains poorly understood. This study aimed to exam...
ORIGINAL ARTICLE 2025 October 27
Efficacy and safety of high-dose hypofractionated palliative radiotherapy (40 Gy in 10 daily fractions) for non–small cell lung cancer
Purpose: Palliative thoracic radiotherapy plays a crucial role in the management of patients with non–small cell lung cancer (NSCLC). Conventional dose-fractionation schemes often yield modest and short-lived tumor responses. This study aims to evaluate the efficacy and safety ...
ORIGINAL ARTICLE 2025 December 15
Machine learning–based prediction of severe oral mucositis from head and neck cancer radiation therapy
Purpose: This study aimed to develop prediction models for severe oral mucositis (OM) (grade ≥ 3) from head and neck cancer (HNC) radiotherapy (RT) using machine learning (ML) techniques and different types of features, including clinical, dose-volume metric, and radiomic featu...
ORIGINAL ARTICLE 2025 December 5
Histopathological risk stratification for early-stage endometrial cancer patients receiving adjuvant vaginal brachytherapy
Purpose: This study aims to figure out prognostic factors affecting treatment outcomes for early-stage endometrial cancer patients undergoing adjuvant vaginal brachytherapy (VBT) and to develop a histopathological risk stratification model. Materials and Methods: We retrospecti...
CASE REPORT 2025 December 19
Radiation therapy in a ductal carcinoma in situ patient with ornithine transcarbamylase deficiency: a case report
Ornithine transcarbamylase (OTC) deficiency is a rare urea cycle disorder that impairs ammonia detoxification, increasing the risk of hyperammonemic crises under metabolic stress. While chemotherapy-related risks have been reported, data on the safety of ionizing radiation thera...

If anyone registers his/her email address, he or she will receive the email of notification when new paper is published in the web site of Radiation Oncology Journal. Since it is open access journal, the full text is freely available.
Please Sign up.
Current Issue
Volume 43(4); December 2025
Original Articles
Systemic immune-inflammation index prior to postoperative radiotherapy as a tool for outcome prediction in thymic epithelial tumors
Alper Kahvecioglu, Mervenur Bay, Pervin Hurmuz, Mustafa Cengiz
Radiat Oncol J. 2025;43(4):165-171.   Published online August 27, 2025

Purpose: The systemic immune-inflammation index (SII) is a prognostic biomarker in various solid tumors. However, the prognostic role of SII in thymic epithelial tumors (TETs) receiving adjuvant radiotherapy (RT) has not yet been explored. This study aims to assess the prognostic role of pre-RT SII in TET patients undergoing adjuvant RT. Materials and Methods: A retrospective analysis was conducted on 37...
Postmastectomy radiation therapy for patients with pT1-2N1 breast cancer over 2 decades in Korea: Korean Radiation Oncology Group 14-21
Mi Sun Kim, Seung Do Ahn, Yong Bae Kim, Won Park, Shin-Hyung Park, Ik Jae Lee, Byung-Ock Choi, Juri Kim, Sung Ja Ahn, Won Sup Yoon, Jin-hee Kim, Jong Hoon Lee, Donghyun Kim, Hye Li Park, Yeon-Joo Kim, Sun Young Lee, Kyung Ran Park, Division for Breast Cancer, Korean Radiation Oncology Group
Radiat Oncol J. 2025;43(4):172-180.   Published online December 8, 2025

Purpose: This study investigates patterns of postmastectomy radiation therapy (PMRT) use in patients with pT1–2N1 breast cancer treated with mastectomy in Korea over 2 decades. Materials and Methods: Data from 700 patients treated at 16 institutions across three decades (1990, 2000, and 2010) were retrospectively reviewed. Results: Overall, 10.0% of patients received PMRT, with utilization rates of 7.4%, 8.8%, and 11.1% in...
Can lymphocytic toxicity be induced by radiation dose to the bowel bag in whole pelvic radiotherapy?
Min Kyun Ko, Kyu Hye Choi, Wonmo Sung, Ji Hyun Hong, Seok Hyun Son, Young-nam Kang, Byung-Ock Choi, Yeon-Sil Kim, HongSeok Jang
Radiat Oncol J. 2025;43(4):181-187.   Published online December 8, 2025

Purpose: Lymphocytopenia is a known side effect of radiation exposure to the bone marrow. However, the hematological impact of irradiating the bowel bag—a highly vascularized region containing numerous mesenteric lymph nodes—remains poorly understood. This study aimed to examine whether radiation to the bowel bag leads to a decrease in absolute lymphocyte count (ALC) during pelvic radiotherapy. Materials and Methods: We retrospectively...
Efficacy and safety of high-dose hypofractionated palliative radiotherapy (40 Gy in 10 daily fractions) for non–small cell lung cancer
James C. H. Chow, Jeffrey C. F. Lui, Chris K. C. Tong, Anthony H. P. Tam, Jeffrey C. H. Chan, Jeannie Y. K. Chik, Gavin T. C. Cheung, Ka Man Cheung, Luke T. Y. Lee, Kam Hung Wong, Kwok Hung Au
Radiat Oncol J. 2025;43(4):188-194.   Published online October 27, 2025

Purpose: Palliative thoracic radiotherapy plays a crucial role in the management of patients with non–small cell lung cancer (NSCLC). Conventional dose-fractionation schemes often yield modest and short-lived tumor responses. This study aims to evaluate the efficacy and safety of a high-dose hypofractionated radiotherapy regimen of 40 Gy in 10 daily fractions in NSCLC. Materials and Methods: Consecutive NSCLC patients who...
Machine learning–based prediction of severe oral mucositis from head and neck cancer radiation therapy
Kanyapat Buasawat, Sasikarn Chamchod, Todsaporn Fuangrod, Sawanee Suntiwong, Kiattiyot Chantarak, Pasit Jarutatsanangkoon, Thiansin Liamsuwan
Radiat Oncol J. 2025;43(4):195-205.   Published online December 15, 2025

Purpose: This study aimed to develop prediction models for severe oral mucositis (OM) (grade ≥ 3) from head and neck cancer (HNC) radiotherapy (RT) using machine learning (ML) techniques and different types of features, including clinical, dose-volume metric, and radiomic features. Materials and Methods: Retrospective data of 148 HNC RT patients were collected and randomly divided into 80% training and 20%...
Histopathological risk stratification for early-stage endometrial cancer patients receiving adjuvant vaginal brachytherapy
Hae Sol Lim, Won Park, Won Kyung Cho, Jeong-Won Lee, Chel Hun Choi, Tae-Joong Kim, Yoo-Young Lee
Radiat Oncol J. 2025;43(4):206-213.   Published online December 5, 2025

Purpose: This study aims to figure out prognostic factors affecting treatment outcomes for early-stage endometrial cancer patients undergoing adjuvant vaginal brachytherapy (VBT) and to develop a histopathological risk stratification model. Materials and Methods: We retrospectively reviewed International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer patients who underwent primary surgery followed by VBT from January 2010 to December 2022....
Case Report
Radiation therapy in a ductal carcinoma in situ patient with ornithine transcarbamylase deficiency: a case report
Iris Kang, Justin Park, Christine Yang, Aster Kim, Mary Tang, Kaye Lu, Azadeh Carr, Stephen F. Sener, Rachel McGowan, Shoji Yano, Stella K. Yoo
Radiat Oncol J. 2025;43(4):214-219.   Published online December 19, 2025
Ornithine transcarbamylase (OTC) deficiency is a rare urea cycle disorder that impairs ammonia detoxification, increasing the risk of hyperammonemic crises under metabolic stress. While chemotherapy-related risks have been reported, data on the safety of ionizing radiation therapy (RT) in this population are limited. This case describes a 30-year-old woman with late-onset OTC deficiency diagnosed with right-sided ductal carcinoma in situ....
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 2.2
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next